TRAIL in CD8+T cells from patients with severe aplastic anemia

被引:9
作者
Liu, Chunyan [1 ]
Zheng, Mengying [1 ]
Zhang, Tian [1 ]
Fu, Rong [1 ]
Wang, Huaquan [1 ]
Wang, Ting [1 ]
Qi, Weiwei [1 ]
Shao, Zonghong [1 ,2 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Hematol, 154 Anshandao, Tianjin 300052, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Dept Hematol, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
Severe aplastic anemia; CTL; TRAIL; APOPTOSIS; EXPRESSION;
D O I
10.1007/s12185-017-2279-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe aplastic anemia (SAA) is an autoimmune disease caused mainly by activated T lymphocytes. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of TNF family, which can induce apoptosis and play a significant role in the pathogenesis of many autoimmune disorders. In this study, we sought to investigate the role of TRAIL in peripheral CD8+ T cells (CTLs) from SAA patients to clarify the autoimmune mechanisms of bone marrow failure in SAA. The expression of TRAIL and TRAIL-R2 in CTLs from SAA patients and normal controls were determined by flow cytometry, real-time PCR, and western blot. Expression of perforin and granzyme B and apoptosis in CTLs were evaluated by flow cytometry. The expression of TRAIL and TRAIL-R2 in SAA patients was significantly decreased compared with controls; however, there was no statistical difference in TRAIL mRNA expression between the two groups. TRAIL expression in CTLs was negatively correlated with the expression of perforin and granzyme B, and negatively correlated with CTLs apoptosis in SAA patients. The TRAIL pathway may be responsible for abnormal CTL activation in SAA patients. Further study of TRAIL and its receptors may elucidate the pathogenesis of SAA.
引用
收藏
页码:490 / 499
页数:10
相关论文
共 25 条
[11]   TRAIL-Receptor Costimulation Inhibits Proximal TCR Signaling and Suppresses Human T Cell Activation and Proliferation [J].
Lehnert, Corinna ;
Weiswange, Maxi ;
Jeremias, Irmela ;
Bayer, Carina ;
Grunert, Michaela ;
Debatin, Klaus-Michael ;
Strauss, Gudrun .
JOURNAL OF IMMUNOLOGY, 2014, 193 (08) :4021-4031
[12]   Differential expression of the proteome of myeloid dendritic cells in severe aplastic anemia [J].
Liu, Chunyan ;
Sheng, Weiwei ;
Fu, Rong ;
Wang, Huaquan ;
Li, Lijuan ;
Liu, Hui ;
Shao, Zonghong .
CELLULAR IMMUNOLOGY, 2013, 285 (1-2) :141-148
[13]   Interleukin-1β and tumor necrosis factor (TNF)-α sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity [J].
Mezosi, E ;
Wang, SH ;
Utsugi, S ;
Bajnok, L ;
Bretz, JD ;
Gauger, PG ;
Thompson, NW ;
Baker, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :250-257
[14]   The diagnosis and treatment of aplastic anemia: a review [J].
Miano, Maurizio ;
Dufour, Carlo .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (06) :527-535
[15]   Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent [J].
Pundt, Noreen ;
Peters, Marvin A. ;
Wunrau, Christina ;
Strietholt, Simon ;
Fehrmann, Carsten ;
Neugebauer, Katja ;
Seyfert, Christine ;
van Valen, Frans ;
Pap, Thomas ;
Meinecke, Ingmar .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (01)
[16]   Aplastic Anemia [J].
Schrezenmeier, H. ;
Koerper, S. ;
Hoechsmann, B. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (49) :2503-2506
[17]   Circulating myeloid dendritic cells are increased in individuals with severe aplastic anemia [J].
Shao Zonghong ;
Tu Meifeng ;
Wang Huaquan ;
Xing Limin ;
Wang Jun ;
Fu Rong ;
Liu Hong ;
Wu Yuhong .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) :156-162
[18]   Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia [J].
Solomou, Elena E. ;
Rezvani, Katayoun ;
Mielke, Stephan ;
Malide, Daniela ;
Keyvanfar, Keyvan ;
Visconte, Valeria ;
Kajigaya, Sachiko ;
Barrett, A. John ;
Young, Neal S. .
BLOOD, 2007, 110 (05) :1603-1606
[19]   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression [J].
Song, KM ;
Chen, YG ;
Göke, R ;
Wilmen, A ;
Seidel, C ;
Göke, A ;
Hilliard, B ;
Chen, YH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) :1095-1103
[20]   Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy [J].
Tawdy, Mohamed H. ;
Abd el Nasser, Maged M. ;
Abd el Shafy, Sanaa S. ;
Nada, Mona A. F. ;
El Sirafy, Mohamed Nasr I. ;
Magd, Amany Hussien Abol .
JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (09) :1606-1611